Biochips (microarrays) are modern analytical tools that allow thousands of individual detections to be performed simultaneously in a small amount of sample material. A team led by Mark Somoza from the Faculty of Chemistry at the University of Vienna has now presented a new method in Nature Communications. With this method, commercially available DNA chips can be quickly and easily converted into RNA chips, which are otherwise much more difficult to produce. Such RNA microarrays help to elucidate the still unknown functions of RNA molecules in cells—an important prerequisite for advancing the diagnosis and treatment of diseases such as cancer.
DNA and RNA are both nucleic acids; their best known tasks in our cells are the long-term storage of genetic information in the form of DNA, and RNA as an intermediate species in the biosynthesis of proteins. Commercially available DNA microarrays are used by default to perform high-throughput genome analyses. For example, they are regularly used in the diagnosis of various hereditary diseases and cancer. They consist of a solid carrier, for example a small glass plate, on which a large number of different DNA molecules are bound. The special feature is, on the one hand, that for each of these variants their exact position on the surface is known. On the other hand, they can be extremely densely packed, so that hundreds of thousands of different DNA strands can fit on the surface of a thumbnail.
RNA chip production has been difficult up to now
The commercial production of DNA chips is based on the stepwise concatenation of individual DNA building blocks. Although this production method has long been established, it can only be transferred to the synthesis of RNA microarrays to a limited extent. This is because RNA molecules are significantly more unstable. In addition, the individual RNA building blocks bind to each other with less efficiency than their DNA equivalents when building the RNA strand. This effect limits the possible length of the RNA strand. “However, to study the still unknown roles of cellular RNA molecules in particular, chips with significantly longer RNA strands are required than previously achievable with chemical synthesis of RNA microarrays. Our new method now solves this problem,” explains first author Erika Schaudy, a young scientist in Mark Somoza’s group at the Institute of Inorganic Chemistry at the University of Vienna.
Targeted use of enzymes makes it possible
As the Viennese research team has now shown, the DNA sequences available on commercial chips can be rewritten into their complementary RNA strands in a length-independent manner through the targeted use of enzymes. Further enzymes then selectively degrade the DNA templates resulting in an RNA chip.
“The outstanding thing is that the fabrication method we developed is based solely on commercially available materials and reagents. Specialized laboratory equipment is unnecessary. This now enables researchers from a wide range of disciplines to produce themselves RNA microarrays that are precisely tailored to their scientific questions,” says Schaudy.
Mark Somoza, who also heads a research group at the Leibniz Institute for Food Systems Biology at the Technical University of Munich, adds that “with this fast and easy-to-perform methodology, we have also created an important basis for further potential applications. For example, RNA technology could equally help to investigate the influence of food compounds on cellular processes and thus human health.”
More information:
Erika Schaudy et al, Simple synthesis of massively parallel RNA microarrays via enzymatic conversion from DNA microarrays, Nature Communications (2022). DOI: 10.1038/s41467-022-31370-9
Provided by
University of Vienna
Citation:
Progress in bioanalytics: Production of RNA chips significantly simplified (2022, July 26)
